Medicilon's preclinical pharmacology and toxicology research team is equipped with a professional send format conversion team and has established a send data conversion platform that is fully developed in terms of software, technology, specification and quality, to realize accurate data conversion and provide a good environment for electronic data submission. In recent years, Medicilon SEND team helped customers complete many send data conversion projects within very tight timeline and filed timely with FDA.

• Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae
• PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects

Cambridge, UK – November 15, 2024 – Stilla Technologies, a global leader in digital PCR (dPCR) solutions, has announced a strategic partnership with Source BioScience, a leading UK-based genomics service provider. This collaboration will bring cutting-edge dPCR technology to the forefront of molecular genetics in the UK and Ireland, with Source BioScience becoming the first provider in the region to offer Stilla’s NIO system.

A fantastic result for the Cushman & Wakefield EMEA Research and Insight team, taking the top spots at The Ian Cullen Research Prize at the Society of Property Researchers Annual Dinner.

The prize is for presentation of new data, innovative analysis and new ways of thinking.

The shortlist for the Open prize whittled down to just two papers – both by Cushman & Wakefield – Kiran Patel’s Locating Science and Sally Bruer’s European City Logistics.

The final selection for best research paper was awarded to Kiran Patel for Locating Science.